José Javier López-Cano

Thermo-Responsive PLGA-PEG-PLGA Hydrogels as Novel Injectable Platforms for Neuroprotective Combined Therapies in the Treatment of Retinal Degenerative Diseases

José Javier López-Cano, A Sigen, Vanessa Andrés‐Guerrero et al. · Pharmaceutics · 2021 · 60 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents

Sergio Esteban-Pérez, Vanessa Andrés‐Guerrero, José Javier López-Cano et al. · Pharmaceutics · 2020 · 46 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments

José Javier López-Cano, Miriam Ana González-Cela-Casamayor, Vanessa Andrés‐Guerrero et al. · Experimental Eye Research · 2021 · 34 citations · Full text

Medicine, Ophthalmology, Pharmacology +14

Osmoprotectants in Hybrid Liposome/HPMC Systems as Potential Glaucoma Treatment

Miguel Gómez-Ballesteros, José Javier López-Cano, Irene Bravo‐Osuna et al. · Polymers · 2019 · 31 citations · Full text

Pharmacy, Ophthalmology, Pharmacology +17

Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment

Miriam Ana González-Cela-Casamayor, José Javier López-Cano, Irene Bravo‐Osuna et al. · Pharmaceutics · 2022 · 20 citations · Full text

Pharmacy, Ophthalmology, Pharmacology +17